AR033808A1 - Una composicion topica de anestesia local y los parches y los envases que la contienen - Google Patents

Una composicion topica de anestesia local y los parches y los envases que la contienen

Info

Publication number
AR033808A1
AR033808A1 ARP010101125A ARP010101125A AR033808A1 AR 033808 A1 AR033808 A1 AR 033808A1 AR P010101125 A ARP010101125 A AR P010101125A AR P010101125 A ARP010101125 A AR P010101125A AR 033808 A1 AR033808 A1 AR 033808A1
Authority
AR
Argentina
Prior art keywords
patches
topical composition
containers containing
local anesthesia
composition
Prior art date
Application number
ARP010101125A
Other languages
English (en)
Original Assignee
Epicept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epicept Inc filed Critical Epicept Inc
Publication of AR033808A1 publication Critical patent/AR033808A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Abstract

Método no invasivo y no sistémico para administrar un anestésico local. El método comprende la aplicación tópica de un anestésico local en combinación con un agente de penetración intradermal seleccionado del grupo que consiste en una composición de aloe, un triglicérido y una mezcla de los mismos. Composición tópica que comprende un anestésico local, o una de sus sales farmacéuticamente aceptables, y un agente de penetración intradermal elegido entre un triglicérido, una composición de aloe y sus mezclas. Parches y envases que contienen dicha composición de uso tópico.
ARP010101125A 2000-03-10 2001-03-09 Una composicion topica de anestesia local y los parches y los envases que la contienen AR033808A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/523,652 US6455066B1 (en) 2000-03-10 2000-03-10 Intradermal-penetration agents for topical local anesthetic administration

Publications (1)

Publication Number Publication Date
AR033808A1 true AR033808A1 (es) 2004-01-07

Family

ID=24085856

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101125A AR033808A1 (es) 2000-03-10 2001-03-09 Una composicion topica de anestesia local y los parches y los envases que la contienen

Country Status (18)

Country Link
US (2) US6455066B1 (es)
EP (1) EP1313456A2 (es)
JP (1) JP2003526678A (es)
KR (1) KR100764156B1 (es)
AR (1) AR033808A1 (es)
AU (2) AU2001245449B2 (es)
BR (1) BR0109150A (es)
CA (1) CA2402296A1 (es)
CZ (1) CZ20023030A3 (es)
HU (1) HUP0300472A3 (es)
IL (2) IL151671A0 (es)
MX (1) MXPA02008828A (es)
NO (1) NO20024309L (es)
NZ (1) NZ521470A (es)
PL (1) PL203847B1 (es)
RU (1) RU2002126999A (es)
SK (1) SK12962002A3 (es)
WO (1) WO2001068138A2 (es)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
EP1170020A4 (en) * 1999-12-27 2009-05-06 Teikoku Seiyaku Kk EXTERNAL USE PADS
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
DE10025890A1 (de) * 2000-05-25 2001-11-29 Euro Celtique Sa Dosierung von transdermalen Arzneimittelsystemen
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
US6500408B2 (en) 2001-01-27 2002-12-31 Jc Technologies, Inc. Enamel-safe tooth bleach and method for use
US6777000B2 (en) 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
CA2440884C (en) * 2001-03-16 2012-05-22 Alza Corporation Transdermal patch for administering fentanyl
US20030082225A1 (en) * 2001-10-19 2003-05-01 Mason Paul Arthur Sterile, breathable patch for treating wound pain
US6703398B2 (en) * 2001-11-26 2004-03-09 Oliver Yoa-Pu Hu Orally administered analgesic compositions containing nalbuphine
DE10158199A1 (de) * 2001-11-27 2003-06-18 Beiersdorf Ag Juckreizstillende kosmetische und dermatologische Zubereitungen
US20030118632A1 (en) * 2001-12-26 2003-06-26 Larry Caldwell Methods and compositions for treating carpal tunnel syndrome
AU2003210417B2 (en) * 2002-03-06 2007-10-11 Hexal Ag Transdermal system comprising fentanyl
WO2004098472A1 (en) * 2002-08-30 2004-11-18 Watson Pharmaceuticals, Inc. Transdermal delivery systems and methods
DE10251256A1 (de) * 2002-11-04 2004-05-13 Novosis Ag Transdermales Wirkstoffabgabesystem für Oxybutynin
JP4667369B2 (ja) 2003-03-21 2011-04-13 ネックスメド ホールディングス インコーポレイテッド 早漏を治療するための組成物および方法
US20050042267A1 (en) * 2003-08-20 2005-02-24 Kimberly-Clark Worldwide, Inc. System for providing therapy to a portion of a body
DE10340428B4 (de) 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
EP1768650B1 (en) * 2004-06-04 2008-07-16 Camurus Ab Liquid depot formulations
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070190124A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
US20070189977A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
US20070189978A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for dermally treating musculoskeletal pain
US20080019927A1 (en) * 2004-06-07 2008-01-24 Jie Zhang Compositions and methods for dermally treating neuropathy with minoxidil
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US20070196325A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for dermally treating infections
US20070196457A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070196452A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Flux-enabling compositions and methods for dermal delivery of drugs
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070196323A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US20070189980A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for treating alopecia
US20070196293A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for treating photo damaged skin
US20060029654A1 (en) * 2004-08-04 2006-02-09 Cassel R D Analgesic patch for sports injury rehabilitation medicine and method to alleviate pain
EP2438910A1 (en) * 2004-08-31 2012-04-11 Stiefel Research Australia Pty Ltd Microemulsion & sub-micron emulsion process & compositions
US8449867B2 (en) 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
WO2006036936A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
US20060223788A1 (en) * 2005-03-29 2006-10-05 Cathcart Clifton H Analgesic composition for topical use
JP5666087B2 (ja) 2005-04-06 2015-02-12 アダマス・ファーマシューティカルズ・インコーポレーテッド Cns関連疾患の治療のための方法及び組成物
US9017717B2 (en) * 2006-01-16 2015-04-28 Peach Technologies Llc Bandage for facilitating transdermal respiration and healing
US7582609B2 (en) * 2006-03-01 2009-09-01 Digna Biotech, S.L. Method for the treatment of skin fibrosis and suitable compositions for such treatment
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
CA2655809C (en) * 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
US8318809B2 (en) * 2006-09-21 2012-11-27 Grayson John C Compositions and methods for treating jellyfish stings
DE102006048130A1 (de) * 2006-10-06 2008-04-10 Axxonis Pharma Ag Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil
PT2117521E (pt) 2006-11-03 2012-09-10 Durect Corp Sistemas de administração transdérmica que compreendem bupivacaína
US7829116B2 (en) * 2006-11-14 2010-11-09 Momentive Performance Materials Inc. Adhesive-forming composition and blend of adhesives obtained therefrom
US7976951B2 (en) 2006-11-14 2011-07-12 Momentive Performance Materials Inc. Laminate containing an adhesive-forming composition
WO2008088756A1 (en) * 2007-01-12 2008-07-24 Bridge Pharma, Inc. Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus
WO2008133982A2 (en) * 2007-04-27 2008-11-06 Lectec Corporation Adhesive patch with aversive agent
RU2499583C2 (ru) * 2007-10-15 2013-11-27 Алза Корпорейшн Заместительное трансдермальное введение фентанила один раз в день
WO2009143174A2 (en) * 2008-05-19 2009-11-26 Children's Medical Center Corporation Chemical permeation enhancers enhance nerve blockade by toxins
JP5472756B2 (ja) 2008-10-02 2014-04-16 マイラン・インク 多層接着ラミネートの作製方法
EP2349230A2 (en) 2008-10-06 2011-08-03 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
US8679470B2 (en) * 2008-11-28 2014-03-25 Luromed Llc Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
DE102009008851A1 (de) 2009-02-13 2010-08-19 Amw Gmbh Transdermales System mit Immunmodulator
DE102010048788A1 (de) 2009-02-13 2011-05-19 Amw Gmbh Transdermales System mit Immunmodulator
DE102010046464A1 (de) 2009-03-19 2011-04-21 Amw Gmbh Transdermales System mit Aromatasehemmer
JP5634679B2 (ja) * 2009-03-24 2014-12-03 リンテック株式会社 局所麻酔貼付剤
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
WO2010114973A1 (en) * 2009-04-01 2010-10-07 Jie Zhang Methods for treating myofascial, muscle, and/or back pain
MX2011011698A (es) * 2009-05-04 2012-02-29 Zars Pharma Inc Metodo para tratar dolores asociados con neuroma, entrapamiento nervioso y otras condiciones.
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
EP2461813A4 (en) 2009-08-05 2014-02-19 Univ Wake Forest Health Sciences COMPOSITIONS AND METHODS FOR INDUCING APOPTOSIS IN PROSTATE CANCER CELLS
US8778387B2 (en) * 2009-09-02 2014-07-15 Hyprotek, Inc. Antimicrobial medical dressings and protecting wounds and catheter sites
US8247390B2 (en) * 2009-09-28 2012-08-21 Luromed Llc Modified hydrophilic polymers containing hydrophobic groups
CA2782556C (en) 2009-12-02 2018-03-27 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use
JP5866298B2 (ja) 2010-01-22 2016-02-17 ハイプロテック、 インク. 抗菌剤およびその使用法
DE102010026879A1 (de) 2010-02-11 2011-08-11 AMW GmbH, 83627 Transdermales System mit Immunmodulator
DE102010026883A1 (de) 2010-03-11 2011-12-15 Amw Gmbh Transdermales System mit Aromatasehemmer
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
US20130315977A1 (en) * 2011-02-02 2013-11-28 Hiroo Maeda Transdermal patch
CN103338771B (zh) * 2011-02-02 2016-04-06 日东电工株式会社 贴剂
US8293288B2 (en) 2011-02-23 2012-10-23 Edna Ma Pain relieving composition
US8512768B2 (en) 2011-02-23 2013-08-20 Miss Smarty Pants Enterprises, Inc. Pain relieving composition
EP2683359B1 (en) * 2011-03-07 2015-04-22 3M Innovative Properties Company Microneedle devices and methods
US9925264B2 (en) 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
EP3569227A1 (en) 2011-05-10 2019-11-20 Itochu Chemical Frontier Corporation Non-aqueous patch
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
DK2823815T3 (en) 2011-09-27 2018-08-06 Itochu Chemical Frontier Corp NON-DIFFICULT PLASTER
US9039967B2 (en) 2012-02-06 2015-05-26 Hyprotek, Inc. Antiseptic applicators and packaging techniques
KR102098980B1 (ko) 2012-07-26 2020-04-08 카무러스 에이비 오피오이드 제형
WO2014123100A1 (ja) * 2013-02-05 2014-08-14 リンテック株式会社 貼付型表面麻酔剤
AU2014239687B2 (en) * 2013-03-15 2018-04-05 Nal Pharmaceutical Group Limited Transdermal drug delivery system containing rivastigmine
PE20160011A1 (es) 2013-03-15 2016-02-10 Childrens Medical Center Formulaciones combinadas de neosaxitoxina para una anestesia local prolongada
WO2014204933A1 (en) 2013-06-17 2014-12-24 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use
EP3474831A1 (en) 2016-06-23 2019-05-01 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
WO2018022814A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
MX2019001104A (es) 2016-07-27 2019-10-02 Corium Int Inc Sistemas de suministro transdermico de memantina.
KR20230109782A (ko) 2016-07-27 2023-07-20 코리움, 엘엘씨 아민 약물의 나트륨 바이카보네이트 제자리 전환 구동된경피성 전달
US11173132B2 (en) 2017-12-20 2021-11-16 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
WO2019194871A1 (en) * 2018-04-05 2019-10-10 Erbst Steven Robert Therapeutic elastic bandage for modulating the endocannabinoid system
CN108853312B (zh) * 2018-09-25 2021-04-16 陕西天宇制药有限公司 聚桂醇外用凝胶及其制备方法
US11481438B2 (en) * 2020-05-26 2022-10-25 Hulu, LLC Watch sequence modeling for recommendation ranking
CN112438963A (zh) * 2020-11-11 2021-03-05 长沙晶易医药科技有限公司 一种利多卡因-丙胺卡因药物组合物的外用制剂及其应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US720962A (en) * 1900-07-07 1903-02-17 Casimir Pauthonier Incandescent electric lamp.
US3892853A (en) 1967-05-22 1975-07-01 Aloe 99 & 0 Inc Stabilized aloe vera gel and preparation of same
US3814095A (en) 1972-03-24 1974-06-04 H Lubens Occlusively applied anesthetic patch
DE2823174A1 (de) 1977-07-06 1979-01-25 Astra Laekemedel Ab Arzneimittel fuer die prophylaktische behandlung postoperativer tiefer venenthrombose
US4748022A (en) 1985-03-25 1988-05-31 Busciglio John A Topical composition
DE3522060A1 (de) 1985-06-20 1987-01-08 Liedtke Pharmed Gmbh Arzneipflaster fuer systemische anwendungen
US5272139A (en) 1986-08-27 1993-12-21 Cary George R Jr Amelioration or elimination of postoperative pain
US4917688A (en) 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
US5002974A (en) * 1988-04-04 1991-03-26 Warner-Lambert Co. Anesthetic/skin moisturizing composition and method of preparing same
US5279837A (en) * 1988-10-14 1994-01-18 Hill Richard J Styptic composition
US5411738A (en) 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
DE3919982A1 (de) 1989-06-19 1990-12-20 Liedtke Pharmed Gmbh Orale lipidarzneiform
US5417671A (en) 1990-05-23 1995-05-23 Jackson; Richard R. Medical devices having local anesthetic effect and methods of their manufacture
US5332576A (en) 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
US5229130A (en) 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
US5356811A (en) * 1992-04-21 1994-10-18 Coats Billy C Method of processing stabilized aloe vera gel obtained from the whole aloe vera leaf
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5330452A (en) 1993-06-01 1994-07-19 Zook Gerald P Topical medicating device
US5415866A (en) 1993-07-12 1995-05-16 Zook; Gerald P. Topical drug delivery system
US5466465A (en) 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
DE4416927C1 (de) 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
JP4124495B2 (ja) * 1995-03-22 2008-07-23 天藤製薬株式会社 局所麻酔組成物
DE19524691A1 (de) 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
DE19526031A1 (de) 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Rückenschmerz und Muskelverspannung
DE19526019A1 (de) 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen
US5658583A (en) 1995-07-28 1997-08-19 Zhang; Jie Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
US5720962A (en) 1995-10-04 1998-02-24 Au Pharmaceuticals, Inc. Analgesic lotion for hemorrhoids and method of making such lotion
EP0954260A1 (en) 1996-05-22 1999-11-10 Diversified Pharmaceuticals, Inc. Compositions, methods and devices for the transdermal delivery of drugs
JPH101441A (ja) * 1996-06-14 1998-01-06 Tendou Seiyaku Kk 局所麻酔組成物
US6210705B1 (en) 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
US5955112A (en) 1998-02-11 1999-09-21 Kaplan; Jeffrey Non-stinging styptic pencil
US6120792A (en) 1998-04-29 2000-09-19 Juni; Jack E. Medicated skin patch and method for its use
IL140834A0 (en) * 1998-07-16 2002-02-10 Sloan Kettering Inst Cancer Topical compositions comprising an opioid analgesic and an nmda antagonist
JP4558208B2 (ja) * 1998-11-24 2010-10-06 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 吸収包帯と包帯上の活性成分の分配器として有効なコーティング
WO2001041745A1 (en) 1999-12-10 2001-06-14 Lectec Corporation Anti pruritic patch
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration

Also Published As

Publication number Publication date
NO20024309D0 (no) 2002-09-09
PL203847B1 (pl) 2009-11-30
SK12962002A3 (sk) 2003-06-03
HUP0300472A2 (hu) 2003-09-29
IL151671A0 (en) 2003-04-10
AU4544901A (en) 2001-09-24
EP1313456A2 (en) 2003-05-28
CA2402296A1 (en) 2001-09-20
CZ20023030A3 (cs) 2003-06-18
PL357944A1 (en) 2004-08-09
KR100764156B1 (ko) 2007-10-08
WO2001068138A3 (en) 2002-01-17
WO2001068138A2 (en) 2001-09-20
JP2003526678A (ja) 2003-09-09
NO20024309L (no) 2002-10-03
US20030138505A1 (en) 2003-07-24
HUP0300472A3 (en) 2006-07-28
US6455066B1 (en) 2002-09-24
KR20030009385A (ko) 2003-01-29
BR0109150A (pt) 2003-04-22
RU2002126999A (ru) 2004-03-10
MXPA02008828A (es) 2004-10-15
NZ521470A (en) 2004-07-30
IL151671A (en) 2010-02-17
US6746689B2 (en) 2004-06-08
AU2001245449B2 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
AR033808A1 (es) Una composicion topica de anestesia local y los parches y los envases que la contienen
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
CO5070580A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
ES2173978T3 (es) Utilizacion de un alcohol graso insaturado.
ES2487496T3 (es) Agente para aliviar el síndrome metabólico
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
AR033342A1 (es) Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico
BR0107869A (pt) Composições farmacêuticas eletrogiradas
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
AR023806A1 (es) Uso de una mezcla de peptidos para la manufactura de un agente terapeutico para la profilaxis y/o el tratamiento del cancer, las composicionesfarmaceuticas y vacunas que contienen dicha mezcla y los procedimientos de preparacion de dichas composiciones y vacunas
ES2113444T3 (es) Medicamentos.
ES2178479T3 (es) Concentrado de principio activo con formoterol, apto para el almacenamiento.
CO2021000174A2 (es) Composiciones tópicas para el alivio del dolor
AR053541A1 (es) Combinacion de xolair con agente inmunosupresor
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
DE60129849D1 (de) Bioadhäsiver schaumstoffilm mit hinhaltender wirkstoffreigabe
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
SV2002000969A (es) Composicion parenteral reconstituible
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
AR024998A1 (es) Nuevos retinoides para el tratamiento del enfisema
AR017222A1 (es) Procedimiento de utilizacion de un agente que inhibe el desarrollo de p.ovale, en la preparacion de medicamentos
AR019699A1 (es) Composicion farmaceutica para el tratamiento de disfuncion de la evacuacion y uso de la misma para la preparacion de un agente terapeutico

Legal Events

Date Code Title Description
FB Suspension of granting procedure